Alterations of the immune system in ulcerative colitis and Crohn's disease. (Q39639039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Alterations of the immune system in ulcerative colitis and Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

MacDermott RP

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Stenson WF

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

published in

Advances in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

285-328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3284291%20AND%20SRC:MED&resulttype=core&format=json

Mediators of anaphylaxis and inflammation

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Recent developments in "nonspecific" inflammatory bowel disease (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Cell-mediated immunity in gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Ulcerative colitis and HLA phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

HLA-A and -B antigens in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immune status in Crohn's disease. I. Leukocyte and lymphocyte subpopulations in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immune status in Crohn's disease : 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

T lymphocyte subsets in inflammatory bowel disease: peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

The immune competence of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Autoantibodies in human ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunological studies in ulcerative colitis. II. "Colon" antigen and human blood group A- and H-like antigens in germfree rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Antigen from colon of germfree rats and antibodies in human ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunological studies in ulcerative colitis. IV. Origin of autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A Study of the Immunologic Aspects of Chronic Ulcerative Colitis and Transmural Colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Lymphocytotoxic antibody in inflammatory bowel disease. A family study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Lymphocytotoxic and RNA antibodies in inflammatory bowel disease: a comparative study in patients and their families.?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Studies of immune functions of patients with systemic lupus erythematosus. i. dysfunction of suppressor t‐cell activity related to impaired generation of, rather than response to, suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Molecular biology of the H-2 histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A speculative view of the multicomponent nature of T cell antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Evidence for function of Ia molecules on gut epithelial cells in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Lymphotoxin in nonspecific inflammatory bowel disease lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Comparative studies of mononuclear phagocyte function in patients with Crohn's disease and colon neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Deficient cell-mediated cytotoxicity and hyporesponsiveness to interferon and mitogenic lectin activation by inflammatory bowel disease peripheral blood and intestinal mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Human colonic mononuclear cells: studies of cytotoxic function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Rectal mucosal plasma cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

A quantitative study of immunoglobulin containing cells in the differential diagnosis of acute colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunohistochemical changes in morphologically involved and uninvolved colonic mucosa of patients with idiopathic proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Spontaneous suppressor cell function in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunoregulatory function of lamina propria T cells in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

T cell-B cell regulation in the intestinal lamina propria in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Immunoglobulin G (IgG) subclasses and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Significance of immunoglobulin G subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

IgG2 deficiency and ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Heterogeneity of B Cells: Direct Evidence of Selective Triggering of Distinct Subpopulations by Polyclonal Activators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

B cell subsets and differential responses to mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Inhibition of leucocyte motility by drugs used in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Leucocyte function in ulcerative colitis. Quantitative leucocyte mobilisation to skin windows and in vitro function of blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Granulocyte migration in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Defective release of C5a related chemo-attractant activity from complement in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Defective modulation of complement in Crohn's disease. C3b opsonization of zymosan by the alternative pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Colonic and small intestinal response to intravenous prostaglandin F2 alpha and E2 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Studies of prostaglandins and sulphasalazine in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Letter: Rectal bleeding and indomethacin suppositories

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Relationship between Rectal Mucosal Prostaglandin Production and Water and Electrolyte Transport in Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

N-formylmethionyl peptides as chemoattractants for leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Inhibition of platelet thromboxane synthetase by sulfasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn's disease. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960848-2

7 January 2021

10.1016/S0065-2776(08)60848-2

Identifiers

DOI

0 references

1 reference